AzTrials
AzTrials

Medication Management at HomeLinkedCareNCT06728254

Information Systems Connectivity to Improve Medication Process

A study testing medication management in people with Medication Management at Home, run by Peter Putz at 4 sites in Austria.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Linked Care aims to help healthcare professionals (nurses, doctors, pharmacists) interact efficiently and safely with IT support to improve patient information flows. It focuses on the medication ordering process, which currently involves time-consuming steps like calling doctors and traveling to get prescriptions. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Medication Management at Home
What is being tested?
medication management
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
4 sitesAustria
Study dates
7 Jan 2025to 29 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Actively pursuing at least one of the following health professions extramurally: nurse, nursing assistant level 1 or level 2 , elderly specialist caregiver, home care assistant
  • Active maintenance of nursing documentation and use of the duty cell phone
  • Age 18+ years
  • Willing to comply with all study-related procedures and provide informed consent

Who cannot join

None listed.

Trial locations and contacts

4 sites in 1 country.

Austria4 sites
  • Volkshilfe Gesundheits- und Soziale Dienste GmbH

    Linz, 4200

  • Wiener Rotes Kreuz- Rettungs-, Krankentransport-, Pflege- und Betreuungsgesellschaft m.b.H.

    Vienna, 1030

  • Johanniter Österreich Ausbildung und Forschung gem. GmbH

    Vienna, 1210

  • Volkshilfe Wien gemeinnützige Betriebs-GmbH

    Vienna

Other trials in Austria

About this study

Official title: Effects of Care Information Systems Connectivity on Medication Process Efficiency and Quality (Linked Care): Protocol for a Cluster Allocated Controlled Trial

Linked Care aims to help healthcare professionals (nurses, doctors, pharmacists) interact efficiently and safely with IT support to improve patient information flows. It focuses on the medication ordering process, which currently involves time-consuming steps like calling doctors and traveling to get prescriptions. The project targets nursing staff, doctors, pharmacists, and patients, with indirect benefits for hospitals, social welfare organizations, and insurance bodies. This study evaluates the Linked Care solution by addressing the research question: Does an electronic ordering system improve the efficiency and quality of the regular medication process?

Read the detailed description

Background and rationale:

Linked Care aims to provide access to information relevant to care and support beyond the boundaries of the various care settings and primarily supports caregivers in the acquisition and transfer of information. The development of essential standards (e.g., a myCare Info) and the involvement of all affected target groups make it possible to develop practical IT tools for standardized networking in mobile care and nursing. The result will be an integrated, affordable, easy-to-use and well-connected IT system for care and support. The portal can be operated via mobile devices, PC, or tablets.

The McKinsey study demonstrates the significant potential of digitalization in the Austrian healthcare sector. According to this study, there is a 4.7-billion-euro opportunity for Austria. Approximately 70% of the potential benefits of increased productivity accrue to service providers, such as physicians and hospitals. The remaining 30% can be attributed to other players in the system, particularly health insurers, who benefit from reduced service utilization and improved care. Key factors in achieving these benefits include the implementation of the Austrian electronic health record (ELGA) and e-prescribing, which enable efficiency gains of EUR 690 million. Digitization is also sought after by regulators, patients, payers, and service providers in the Austrian healthcare system for improved efficiency and quicker access to data.

Helmcke et al. (2021) identify the following areas with the greatest potential for savings and benefits in the Austrian healthcare system:

  • Online interactions, especially through teleconsultation.
  • Paperless data, emphasizing standardized patient records/exchange and electronic prescriptions.
  • Automated workflows, particularly the networking of mobile caregivers.
  • Decision support and transparency of outcomes, including performance dashboards.
  • Patient self-management, primarily through tools for managing chronic conditions like diabetes.
  • Patient self-service for electronic scheduling.

Objectives:

This project aims to enable documenting healthcare professionals (such as nurses, general practitioners (GPs), and pharmacists) to interact efficiently, safely, and conveniently, with optimal IT support, to improve (or make more efficient) the patient-related information flows. The specific use cases studied are the process of ordering and in particular reordering medication. A significant time-saving potential has been identified in the transfer of medication information. The ordering process usually begins with nurses calling a GP as soon as they notice that a client has run out of medication and needs to be re-supplied when preparing the prescribed medication. The nurse then usually travels distances (e.g. by car) to obtain a prescription from the GP and collect the medication from the pharmacy. To do this, they need the client's insurance card, which has to be collected separately. The project is therefore aimed at four target groups: i) nursing staff who carry out the documentation, ii) GPs, and iii) pharmacists and finally iv) patients who make use of the care. In addition to the target groups studied in this trial, indirect beneficiaries include healthcare providers such as hospitals, social welfare organizations, rehabilitation clinics, public insurance bodies, etc. who ensure effective and efficient care. The trial aims to evaluate the entire process of data recording and data exchange via the newly created interfaces between the systems involved in practical use.

The primary research question of this study is: Does an electronic ordering system improve the efficiency and quality of the regular medication process?

Secondary research questions are:

  • Does the digital ordering system receive end-user acceptance?
  • Which impacts on the health and care system are generated by the implementation of the digital ordering system? (evaluated qualitatively)
Being tested
medication management, Usual Care Group
Keywords
medication process, nursing, telehealth, home care, medication order

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • medication managementDevice

    The test system consists of:

    • Linked care platform (backend) which provides a new possibility of data exchange for IT systems of caregivers, pharmacies, and GPs
    • User interfaces for caregivers as well as for the systems myneva.carecenter and mynevaTOgo
    • An extension of the user interface for GPs in their IT system (in the test only for the physician software PCPO by CompoGroup Medical )
    • An extension of the user interface for pharmacists in their IT system (in the test only for pharmacies with software from Apothekerverlag)

    Functionally, the solution should, coordinate the medication requirements between pharmacies, GPs, and caregivers (subarea medication).

  • Usual Care GroupOther

    Usual care.

Study groups in NCT06728254
Study groupRoleWhat they receive
Intervention (using Linked Care system)ExperimentalAll nurses and caregivers participating in the intervention group use the newly installed mynevaToGo app to reorder medication. Nurses and nursing assistant level 2 also use the myneva Care Center software to keep the medication list prescribed by the GP. The solution is installed in advance on the duty cell phones by the IT department of the relevant care organization. Participating nurses and caregivers in the intervention group are instructed to handle the medication ordering process electronically (i.e., medication orders will be sent to the GPs via the Linked Care platform).
Receives: Device: medication management
ControlActive comparatorCare professionals in the convenience sampled control group continue to handle the usual medication process.
Receives: Other: Usual Care Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time spent on medication related processes

    Measure of time efficiency recorded on a project-specific 14-day medication log. / Minimum value: 0 [minutes], maximum value: N/A. Higher scores mean a worse outcome. / Analysis metric: difference test vs. control, test group trend analysis. / Method of aggregation: mean.

    Measured: Baseline, 3-month follow-up, 6-month follow-up

Secondary outcomes (4)
  1. Overall score from the "Survey on psychological stress in mobile care (BGW miab)

    Self-reported indications on 6 subitems on a 5-point Likert pseudometric scale. / Minimum value: 1, maximum value: 5. Higher scores mean a worse outcome. / Analysis metric: Difference test vs. control \& test group trend analysis. / Method of aggregation: mean score.

    Measured: Baseline, 3-month follow-up, 6-month follow-up

  2. Overall score from a "Project-specific questionnaire on care-process quality".

    Self-reported indications on 21 subitems on a 5-point Likert pseudometric scale. / Minimum value: 1, maximum value: 5. Higher scores mean a worse outcome. / Analysis metric: Difference test vs. control \& test group trend analysis. / Method of aggregation: weighted mean score.

    Measured: Baseline, 3-month follow-up, 6-month follow-up

  3. Overall score from the "Usefulness, Satisfaction, and Ease of Use (PSSUQ) Questionnaire"

    Self-reported indications on 16 subitems on a 7-point Likert pseudometric scale. / Minimum value: 1, maximum value: 7. Higher scores mean a worse outcome. / Analysis metric: Difference test vs. control \& test group trend analysis. / Method of aggregation: mean score.

    Measured: 3-month follow-up, 6-month follow-up

  4. Overall score from the "Unified Theory of Acceptance and Use of Technology 2 (UTAUT2) Questionnaire"

    Self-reported indications on a 7-point Likert pseudometric scale with subitems in 4 domains: i) performance expectancy, ii) effort expectancy, iii) social influence, and iv) facilitating conditions. / Minimum value: 1, maximum value: 7. Higher scores mean a worse outcome. / Analysis metric: Difference test vs. control \& test group trend analysis. / Method of aggregation: mean score.

    Measured: 3-month follow-up, 6-month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Dec 2024
  2. Study start7 Jan 2025
  3. Primary completion29 Jun 2025
  4. Study completion29 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Non-randomized controlled trial, with participants unequally allocated to test and control groups (factor 5) in clusters
Masking
None (open label)
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06728254
Sponsor's protocol ID
FHCW EC Nr. 130/2023
Acronym
LinkedCare
Status last verified
Sep 2025
First submitted
6 Dec 2024
Last updated
24 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Because the trial deals with sensitive health-related data, neither person-identifiable nor coded raw data will be made publicly available or shared upon request from other researchers.

Publications

  • Helmcke Stefan, Biesdorf Stefan, Bauer Florian, Berger Wernhard (2021). mckinseystudiedigitalisierung im gesundheitswesen die 47mrdeurochance fur Österreich.

  • BGW miab für die Pflege und den stationären Wohnbereich der Behindertenhilfe Erstveröffentlichung 2002, Stand 01/2013 Hrsg. Berufsgenossenschaft für Gesundheitsdienst und Wohlfahrtspflege (BGW). Hamburg, Online: www.bgw-online.de

Questions about this trial

What is this clinical trial studying?

A study testing medication management in people with Medication Management at Home, run by Peter Putz at 4 sites in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time spent on medication related processes (time frame: Baseline, 3-month follow-up, 6-month follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06728254, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in